Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2008

View Archived Issues

Ablynx reports phase Ib results for antithrombotic nanobody ALX-0081

Milatuzumab safe in first trial in multiple myeloma

Alimera Sciences initiates pilot study to assess safety and efficacy of Iluvien

CHMP grants positive opinion for approval of Japanese Encephalitis vaccine

Potential of antileukemia combination therapy including DL-11-5908 demonstrated

Phase I and II study data for voreloxin in acute myeloid leukemia reported

FDA approves Athersys' IND to initiate phase I clinical trial of MultiStem in ischemic stroke

FDA issues complete response letter denying approval to Pain's NDA for Remoxy

FDA accepts for review Merck & Co.'s sNDA for Isentress for treatment-naive HIV-1 patients

Health Canada grants permission to EpiCept to proceed with NDS for Ceplene in AML

Companies respond to FDA panel's recommendations on LABAs in asthma

FDA accepts for review Barr's BLA for adenovirus types 4 and 7 live oral vaccines

Genta to appeal FDA negative decision on NDA for Genasense in CLL

SARcode completes phase I clinical trial of SAR-1118 for ocular inflammation

Oncolytics Biotech reports positive interim results from REO-014 phase II clinical trial of Reolysin

Phase IIa clinical trial results of LX-6171 in AAMI lead to reevaluation of future development

BioDelivery Sciences resubmits NDA for Onsolis to FDA

Health Canada approves lower dose of Bristol-Myers Squibb's Sprycel for chronic phase CML

Celsion enters exclusive Japan license agreement with Yakult Honsha for ThermoDox

Neratinib shows potent antitumor activity in advanced breast cancer phase II study

BioCancell submits IND applications for BC-819 in pancreatic and ovarian cancer

Clinical safety data supports preclinical evaluation of (+)-enantiomer of mefloquine in malaria

Recent patents report new therapeutic options for respiratory disorders

New antiinflammatory agents disclosed in recent Toyama and Galapagos patents

Novel analgesic agents imparted in recent patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...